193 related articles for article (PubMed ID: 18470485)
21. [Practical aspects and clinical value of t(14;18) monitoring in peripheral blood of the follicular lymphoma patients].
Janíková-Oborilová A; Mayer J; Dvorákova D; Mejstrík P; Navritíl M; Vásová I; Kren L; Matuska M
Cas Lek Cesk; 2007; 146(4):374-81; discussion 381-2. PubMed ID: 17491248
[TBL] [Abstract][Full Text] [Related]
22. Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy.
Czuczman MS; Grillo-López AJ; McLaughlin P; White CA; Saleh M; Gordon L; LoBuglio AF; Rosenberg J; Alkuzweny B; Maloney D
Ann Oncol; 2001 Jan; 12(1):109-14. PubMed ID: 11249036
[TBL] [Abstract][Full Text] [Related]
23. [Detection and diagnostic value of t(14;18) translocation in minimal residual disease of follicular lymphoma].
Bessenyei B; Urbán L; Takács I; Zeher M; Szegedi G; Semsei I
Orv Hetil; 2000 Jul; 141(31):1715-9. PubMed ID: 10976195
[TBL] [Abstract][Full Text] [Related]
24. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
Limpens J; de Jong D; van Krieken JH; Price CG; Young BD; van Ommen GJ; Kluin PM
Oncogene; 1991 Dec; 6(12):2271-6. PubMed ID: 1766674
[TBL] [Abstract][Full Text] [Related]
25. Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.
Ha CS; Cabanillas F; Lee MS; Besa PC; McLaughlin P; Cox JD
Clin Cancer Res; 1997 Feb; 3(2):215-9. PubMed ID: 9815675
[TBL] [Abstract][Full Text] [Related]
26. Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma.
Berinstein NL; Reis MD; Ngan BY; Sawka CA; Jamal HH; Kuzniar B
J Clin Oncol; 1993 Jul; 11(7):1344-52. PubMed ID: 8315432
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study.
Hill ME; MacLennan KA; Cunningham DC; Vaughan Hudson B; Burke M; Clarke P; Di Stefano F; Anderson L; Vaughan Hudson G; Mason D; Selby P; Linch DC
Blood; 1996 Aug; 88(3):1046-51. PubMed ID: 8704213
[TBL] [Abstract][Full Text] [Related]
28. Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation.
Hirt C; Dölken G
Bone Marrow Transplant; 2000 Feb; 25(4):419-26. PubMed ID: 10723586
[TBL] [Abstract][Full Text] [Related]
29. [Detection of t (14; 18) chromosomal translocation in paraffin-embedded tissues of follicular lymphoma and its clinical significance].
Zhang PH; Zhou XY; Shui RH; Zhang TM; Zheng AH; Guo XH; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):600-4. PubMed ID: 18070448
[TBL] [Abstract][Full Text] [Related]
30. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and prognostic utility of t(14;18) in follicular lymphoma.
Deghiedy H; Fouda M; Shahin D; Shamaa S; El-Bedewy A; Abd El-Ghaffar H
Acta Haematol; 2007; 118(4):231-6. PubMed ID: 18075243
[TBL] [Abstract][Full Text] [Related]
32. Quantitative PCR detection of t(14;18) bcl-2/JH fusion sequences in follicular lymphoma patients: comparison of peripheral blood and bone marrow aspirate samples.
Bowman A; Jones D; Medeiros LJ; Luthra R
J Mol Diagn; 2004 Nov; 6(4):396-400. PubMed ID: 15507680
[TBL] [Abstract][Full Text] [Related]
33. Primary cutaneous follicular lymphoma: a clinicopathologic and molecular study of 16 cases in support of a distinct entity.
Goodlad JR; Krajewski AS; Batstone PJ; McKay P; White JM; Benton EC; Kavanagh GM; Lucraft HH;
Am J Surg Pathol; 2002 Jun; 26(6):733-41. PubMed ID: 12023577
[TBL] [Abstract][Full Text] [Related]
34. First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.
Walewski J; Paszkiewicz-Kozik E; Michalski W; Rymkiewicz G; Szpila T; Butrym A; Giza A; Zaucha JM; Kalinka-Warzocha E; Wieczorkiewicz A; Zimowska-Curyło D; Knopińska-Posłuszny W; Tyczyńska A; Romejko-Jarosińska J; Dąbrowska-Iwanicka A; Gruszecka B; Jamrozek-Jedlińska M; Borawska A; Hołda W; Porowska A; Romanowicz A; Hellmann A; Stella-Hołowiecka B; Deptała A; Jurczak W
Br J Haematol; 2020 Mar; 188(6):898-906. PubMed ID: 31792945
[TBL] [Abstract][Full Text] [Related]
35. Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics.
Jardin F; Gaulard P; Buchonnet G; Contentin N; Leprêtre S; Lenain P; Stamatoullas A; Picquenot JM; Duval C; Parmentier F; Tilly H; Bastard C
Leukemia; 2002 Nov; 16(11):2309-17. PubMed ID: 12399977
[TBL] [Abstract][Full Text] [Related]
36. Correlation of t(14;18) translocation breakpoint site with clinical characteristics in follicular lymphoma.
Panjan M; Boltezar L; Novakovic S; Kokovic I; Jezersek Novakovic B
Radiol Oncol; 2023 Dec; 57(4):487-492. PubMed ID: 37439703
[TBL] [Abstract][Full Text] [Related]
37. The indolent course and high incidence of t(14;18) in primary duodenal follicular lymphoma.
Mori M; Kobayashi Y; Maeshima AM; Gotoda T; Oda I; Kagami Y; Bennett S; Nomoto J; Azuma T; Yokoyama H; Maruyama D; Kim SW; Watanabe T; Matsuno Y; Tobinai K
Ann Oncol; 2010 Jul; 21(7):1500-1505. PubMed ID: 20022910
[TBL] [Abstract][Full Text] [Related]
38. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.
Schmitt C; Balogh B; Grundt A; Buchholtz C; Leo A; Benner A; Hensel M; Ho AD; Leo E
Leuk Res; 2006 Jun; 30(6):745-50. PubMed ID: 16297448
[TBL] [Abstract][Full Text] [Related]
39. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
[TBL] [Abstract][Full Text] [Related]
40. High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150.
Lichtman SM; Petroni G; Schilsky RL; Johnson JL; Perri RT; Niedzwiecki D; Sklar J; Barcos M; Peterson BA
Leuk Lymphoma; 2001; 42(6):1255-64. PubMed ID: 11911406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]